TD-1

• UNSPSC Description :

  TD-1 (Transdermal peptide) is a short peptide that can promote the delivery of macromolecule drugs, especially protein drugs, through the skin barrier. TD-1 can significantly improve the transdermal delivery efficiency of protein drugs such as insulin and human growth hormone, allowing them to reach systemic circulation. Research on TD-1 transdermal drug delivery system[1].

• Target Antigen :

  Others

• Type :

  Peptides

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/td-1.html

• Smiles :

  O=C(O)CNC([C@H](CS)NC([C@H](CC1=CNC=N1)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H]2N(C([C@H](CO)NC([C@H](CO)NC([C@H](CO)NC([C@H](CS)NC([C@H](C)N)=O)=O)=O)=O)=O)CCC2)=O)=O)=O)=O)=O

• Molecular Weight :

  1063.17

• References & Citations :

  [1]Chen Y, et al. Transdermal protein delivery by a coadministered peptide identified via phage display[J]. Nature biotechnology, 2006, 24(4): 455-460.

• Shipping Conditions :

  Room temperature

• Clinical Information :

  No Development Reported

• CAS Number :

  [918629-48-8]